Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
A: The response time varies depending on the individual and the type of pain
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinsons disease
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils
Starting at $495 Retatrutide (Triple-agonist GLP-1/GIP/Glucagon) Investigational triple agonist (GLP-1/GIP/glucagon) being studied for advanced metabolic and weight loss research
Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome
US$ 25.35
US$ 25.47
US$ 28.85
US$ 22.65
US$ 23.62
US$ 20.47
US$ 20.56
US$ 21.38
US$ 24.13
